About this Research Topic
This Research Topic aims at elaborating the progress on the clinical utility of emerging biomarkers that are used for auxiliary early diagnosis, treatment decisions and postoperative surveillance for patients with GI cancers (excluding Gastric cancer). We also would like to discuss the continued prospective validation of biomarkers along with further developments in patient molecular profiling technologies which will help to achieve the goal of true individualized therapy.
We welcome submissions of Review, Mini Review, Original Research, and Clinical Trial on the sub-themes below for GI cancer (excluding Gastric Cancer) patients, which will be related to circulating tumor cells, miRNAs, tumor microenvironment, and new therapeutic regimen.
• Predictive or prognostic biomarkers that can be used for individualized treatment.
• Predictive or prognostic biomarkers that can be used to predict the oncological outcomes or toxicities.
• Biomarkers related to cancer metabolism or drug-resistance.
Note: submissions on similar topics for Gastric cancer are not in scope of this Research Topic and need to be submitted to the Research Topics "Gastric Cancer Phenotype and Treatment" at https://www.frontiersin.org/research-topics/14602 or "Molecular Biomarkers for Gastric Cancer" at https://www.frontiersin.org/research-topics/13667.
Keywords: biomarker landscape, gastrointestinal cancer, early detection, postoperative surveillance
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.